| 1.
|
Introduction to Evolving Treatment Strategies for Chronic Hepatitis B |
[Video]
[Audio]
[Text]
|
| 2.
|
What is the prevalence rate of chronic hepatitis B in the world? |
[Video]
[Audio]
[Text]
|
| 3.
|
How many people have chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 4.
|
What is the natural history and progression of hepatitis B? |
[Video]
[Audio]
[Text]
|
| 5.
|
What is the natural clearance rate of the surface and e-antigen? |
[Video]
[Audio]
[Text]
|
| 6.
|
What is the risk of liver cancer for someone with active chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 7.
|
Is the presence of hepatitis B DNA associated with increased risk of liver cancer? |
[Video]
[Audio]
[Text]
|
| 8.
|
Is there more than one type of hepatitis B virus? |
[Video]
[Audio]
[Text]
|
| 9.
|
What is e-antigen negative chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 10.
|
Are there different genotypes of the hepatitis B virus? |
[Video]
[Audio]
[Text]
|
| 11.
|
What are the demographics of hepatitis B genotypes in the US? |
[Video]
[Audio]
[Text]
|
| 12.
|
Is the response to therapy related to HBV genotypes? |
[Video]
[Audio]
[Text]
|
| 13.
|
What are the phases of chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 14.
|
How do doctors assess chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 15.
|
What are the serological markers for hepatitis B? |
[Video]
[Audio]
[Text]
|
| 16.
|
What are the AASLD Practice Guidelines for treatment of chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 17.
|
Are there other counseling recommendations for someone with chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 18.
|
Should someone with chronic hepatitis B be screened for liver cancer? |
[Video]
[Audio]
[Text]
|
| 19.
|
What are the licensed treatments for chronic hepatitis B in the US? |
[Video]
[Audio]
[Text]
|
| 20.
|
What are the response, duration and durability for the three hepatitis B treatments? |
[Video]
[Audio]
[Text]
|
| 21.
|
Are there other notable differences between the treatments, including side-effects? |
[Video]
[Audio]
[Text]
|
| 22.
|
Does the hepatitis B virus develop resistance to the anti-viral treatments? |
[Video]
[Audio]
[Text]
|
| 23.
|
Are the oral treatments for hepatitis B complimentary in treating resistance? (lamivudine resistance and adefovir) |
[Video]
[Audio]
[Text]
|
| 24.
|
Are the oral treatments for hepatitis B complimentary in treating resistance? (adefovir resistance and lamivudine) |
[Video]
[Audio]
[Text]
|
| 25.
|
Is pegylated interferon effective in treating chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 26.
|
What is the combined response of treatment between interferon and pegylated interferon? |
[Video]
[Audio]
[Text]
|
| 27.
|
How has the HBV treatment landscape changed? |
[Video]
[Audio]
[Text]
|
| 28.
|
Who participated in writing the HBV Treatment Algorithm? |
[Video]
[Audio]
[Text]
|
| 29.
|
Why was the HBV Treatment Algorithm written? |
[Video]
[Audio]
[Text]
|
| 30.
|
What are the key issues with the current guidelines focused on by the Treatment Algorithm? |
[Video]
[Audio]
[Text]
|
| 31.
|
What are the AASLD Treatment Guidelines for hepatitis B? |
[Video]
[Audio]
[Text]
|
| 32.
|
What are the recommendations made by the treatment Algorithm panel? |
[Video]
[Audio]
[Text]
|
| 33.
|
What is the appropriate DNA level for initiating treatment of chronic hepatitis B? |
[Video]
[Audio]
[Text]
|
| 34.
|
What is the treatment algorithm for patients with HBeAg positive compensated disease? |
[Video]
[Audio]
[Text]
|
| 35.
|
What is the treatment algorithm for patients with HBeAg negative compensated disease? |
[Video]
[Audio]
[Text]
|
| 36.
|
What is the treatment algorithm for patients with compensated cirrhosis? |
[Video]
[Audio]
[Text]
|
| 37.
|
What is the treatment algorithm for patients with decompensated cirrhosis? |
[Video]
[Audio]
[Text]
|
| 38.
|
What are the advantages and disadvantages of the current approved hepatitis B treatments? |
[Video]
[Audio]
[Text]
|
| 39.
|
Are there new treatments on the horizon for treatment of chronic hepatitis B? |
[Video]
[Audio]
[Text]
|